Optical active substances made from chiral catalysis form the basis of many drugs. Expensive precious-metal catalysts are required for the chemical production, which due to their thermal instability decompose at high temperatures and can therefore only be used once. The innovative process of DexLeChem GmbH makes it possible for the first time to use these precious-metal catalysts made from rhodium, ruthenium or iridium more than once, without modifying them. At the same time, reaction occurs in aqueous solutions instead of mineral-oil-based solvents, which increases the sustainability of the process. This is a milestone in catalysis and a real opportunity for the pharmaceutical industry. more